FOLFOX4 matches irinotecan as second-line therapy for advanced CRC. Comment Comment uri icon

Overview

MeSH Major

  • Clinical Trials as Topic
  • Neoplasms
  • Patient Selection
  • Research Subjects

publication date

  • September 2005

Research

keywords

  • Comment

Additional Document Info

start page

  • 37

end page

  • 38

number

  • FALL